|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0017262,
umls-concept:C0040300,
umls-concept:C0086418,
umls-concept:C0185117,
umls-concept:C0205183,
umls-concept:C0205282,
umls-concept:C0332307,
umls-concept:C0376358,
umls-concept:C0683941,
umls-concept:C1947901,
umls-concept:C2911684
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
2011-5-10
|
|
pubmed:abstractText |
A third isozyme of human 5?-steroid reductase, 5?-reductase-3, was identified in prostate tissue at the mRNA level. However, the levels of 5?-reductase-3 protein expression and its cellular localization in human tissues remain unknown.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1097-0045
|
|
pubmed:author |
|
|
pubmed:copyrightInfo |
Copyright © 2010 Wiley-Liss, Inc.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
71
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1033-46
|
|
pubmed:meshHeading |
pubmed-meshheading:21557268-3-Oxo-5-alpha-Steroid 4-Dehydrogenase,
pubmed-meshheading:21557268-Blotting, Western,
pubmed-meshheading:21557268-Cell Line, Tumor,
pubmed-meshheading:21557268-Disease Progression,
pubmed-meshheading:21557268-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:21557268-Epithelial Cells,
pubmed-meshheading:21557268-Humans,
pubmed-meshheading:21557268-Immunohistochemistry,
pubmed-meshheading:21557268-Isoenzymes,
pubmed-meshheading:21557268-Male,
pubmed-meshheading:21557268-Muscle, Skeletal,
pubmed-meshheading:21557268-Prostate,
pubmed-meshheading:21557268-Prostatic Hyperplasia,
pubmed-meshheading:21557268-Prostatic Neoplasms,
pubmed-meshheading:21557268-RNA, Messenger,
pubmed-meshheading:21557268-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:21557268-Tumor Cells, Cultured
|
|
pubmed:year |
2011
|
|
pubmed:articleTitle |
5?-reductase type 3 expression in human benign and malignant tissues: a comparative analysis during prostate cancer progression.
|
|
pubmed:affiliation |
Department of Urology, Roswell Park Cancer Institute, Buffalo, New York 14263, USA.
|
|
pubmed:publicationType |
Journal Article,
Research Support, U.S. Gov't, Non-P.H.S.,
Research Support, N.I.H., Extramural
|
